193 related articles for article (PubMed ID: 25641432)
41. Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: age-period-cohort analysis.
Liu S; Semenciw R; Mao Y
Hematol Oncol; 2003 Jun; 21(2):57-66. PubMed ID: 12802810
[TBL] [Abstract][Full Text] [Related]
42. Risk of second primary cancers among patients with a first primary gastric cancer: A population-based study in North Portugal.
Morais S; Antunes L; Bento MJ; Lunet N
Cancer Epidemiol; 2017 Oct; 50(Pt A):85-91. PubMed ID: 28843176
[TBL] [Abstract][Full Text] [Related]
43. Increasing incidence of non-Hodgkin's lymphoma in Karachi, 1995-2002.
Bhurgri Y; Pervez S; Bhurgri A; Faridi N; Usman A; Kazi LA; Ahmed R; Kayani N; Hasan SH
Asian Pac J Cancer Prev; 2005; 6(3):364-9. PubMed ID: 16236001
[TBL] [Abstract][Full Text] [Related]
44. Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.
Fallah M; Kharazmi E; Pukkala E; Tretli S; Olsen JH; Tryggvadottir L; Sundquist K; Hemminki K
Leukemia; 2016 Feb; 30(2):373-8. PubMed ID: 26442613
[TBL] [Abstract][Full Text] [Related]
45. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
46. Non-Hodgkin lymphoma among young adults with and without AIDS in Italy.
Dal Maso L; Rezza G; Zambon P; Tagliabue G; Crocetti E; Vercelli M; Zanetti R; Falcini F; Tonini G; Mangone L; De Lisi V; Ferretti S; Tumino R; Stanta G; Vitarelli S; Serraino D; Franceschi S;
Int J Cancer; 2001 Aug; 93(3):430-5. PubMed ID: 11433410
[TBL] [Abstract][Full Text] [Related]
47. Season of birth and risk of Hodgkin and non-Hodgkin lymphoma.
Crump C; Sundquist J; Sieh W; Winkleby MA; Sundquist K
Int J Cancer; 2014 Dec; 135(11):2735-9. PubMed ID: 24752499
[TBL] [Abstract][Full Text] [Related]
48. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
49. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study.
Paltiel O; Schmit T; Adler B; Rachmilevitz EA; Polliack A; Cohen A; Haim N; Shachar MB; Epelbaum R; Barchana M; Cohen R; Ben Yehuda D
Cancer; 2000 May; 88(10):2357-66. PubMed ID: 10820359
[TBL] [Abstract][Full Text] [Related]
50. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
Farr DE; Thomas A; Khan SA; Schroeder MC
Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
[TBL] [Abstract][Full Text] [Related]
51. Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database.
Kim JS; Liu Y; Ha KH; Qiu H; Rothwell LA; Kim HC
Cancer Res Treat; 2020 Oct; 52(4):1262-1272. PubMed ID: 32599988
[TBL] [Abstract][Full Text] [Related]
52. Descriptive epidemiology of non-Hodgkin's lymphoma in Oklahoma: 1997-2003.
Bliss A; Buriak S
J Okla State Med Assoc; 2008 Nov; 101(11):262-6. PubMed ID: 19113066
[TBL] [Abstract][Full Text] [Related]
53. Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study.
Neumann F; Jégu J; Mougin C; Prétet JL; Guizard AV; Lapôtre-Ledoux B; Bara S; Bouvier V; Colonna M; Troussard X; Trétarre B; Grosclaude P; Velten M; Woronoff AS
Prev Med; 2016 Sep; 90():52-8. PubMed ID: 27370167
[TBL] [Abstract][Full Text] [Related]
54. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
55. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
56. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
57. Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: A nationwide population-based study.
Chien SH; Liu CJ; Hu YW; Hong YC; Teng CJ; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
Int J Cancer; 2015 Aug; 137(3):658-65. PubMed ID: 25630766
[TBL] [Abstract][Full Text] [Related]
58. Differences in non-Hodgkin lymphoma survival between young adults and children.
Tai E; Pollack LA; Townsend J; Li J; Steele CB; Richardson LC
Arch Pediatr Adolesc Med; 2010 Mar; 164(3):218-24. PubMed ID: 20194253
[TBL] [Abstract][Full Text] [Related]
59. Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study.
Joung JY; Kwon WA; Lim J; Oh CM; Jung KW; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
Cancer Res Treat; 2018 Jan; 50(1):293-301. PubMed ID: 28421722
[TBL] [Abstract][Full Text] [Related]
60. Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.
Rabbani F; Russo P
Urology; 1999 Jul; 54(1):28-33. PubMed ID: 10414722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
